0000000000811941

AUTHOR

Loriana Romeo

showing 2 related works from this author

Alzheimer's disease: new diagnostic and therapeutic tools.

2008

Abstract On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related diseases was held in Palermo, Italy. Here, the lectures of M. Racchi on History and future perspectives of Alzheimer Biomarkers and of G. Scapagnini on Cellular Stress Response and Brain Ageing are summarized. Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease, which in Western society mainly accounts for clinica dementia. AD prevention is an important goal of ongoing research. Two objectives must be accomplished to make prevention feasible: i) individuals at high risk of AD need to be identified before the earliest symptoms become evident, by which time extensive neurodege…

lcsh:Immunologic diseases. AllergyAgingmedicine.medical_specialtyImmunologyShort ReportCellular homeostasisDiseaselcsh:Geriatrics03 medical and health sciences0302 clinical medicineEffective interventionsIntervention (counseling)Cellular stress responsemedicineDementiaIntensive care medicine030304 developmental biologyalzheimer ageing inflammation0303 health sciencesbusiness.industryNeurodegenerationmedicine.disease3. Good healthlcsh:RC952-954.6AgeingAgeingImmunologybusinesslcsh:RC581-607030217 neurology & neurosurgeryImmunityageing : IA
researchProduct

Genetic risk factors and candidate biomarkers for Alzheimer s disease

2009

Alzheimer's disease is a multifactorial and progressive neurodegenerative disease, extremely diffused and with an increasing prevalence worldwide. There is an urgent need for biomarkers to diagnose AD early in its course. Furthermore, accurate biomarkers would be able to determine the clinical efficacy of novel neuroprotective strategies. Although the heritability of late-onset AD is high, our knowledge of the underlying putative susceptibility genes remains incomplete and the only unequivocally established late-onset AD gene is APOE. Nevertheless a number of susceptibility loci seems to influence the pathogenesis of AD, and variations in numerous genes have been considered to be important …

Settore MED/04 - Patologia GeneraleApolipoprotein EAmyloid beta-PeptidesGeneral Immunology and MicrobiologyBiomarkers Alzheimer geneticbusiness.industryBrain dysfunctiontau ProteinsSusceptibility geneDiseaseBioinformaticsNeuroprotectionGeneral Biochemistry Genetics and Molecular BiologyPathogenesisApolipoproteins EAlzheimer DiseaseRisk FactorsSusceptibility locusHumansMedicineGenetic riskbusinessBiomarkersFrontiers in Bioscience
researchProduct